Market Research Report

Pruritus Ani Medicine Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-16373
  • CAT ID : 7
  • Pages : 115
  • Date : Jun 2023
 

The global Pruritus Ani Medicine market was valued at US$ 874.6 million in 2022 and is projected to reach US$ 1197.7 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
External Medication Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pruritus Ani Medicine include AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, GSK plc, Merck & Co., Inc., Pfizer, Inc. and Teva Pharmaceutical Industries Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Pruritus Ani Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Ani Medicine. This report contains market size and forecasts of Pruritus Ani Medicine in global, including the following market information:
Global Pruritus Ani Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pruritus Ani Medicine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pruritus Ani Medicine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pruritus Ani Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pruritus Ani Medicine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pruritus Ani Medicine Market Segment Percentages, by Type, 2022 (%)
External Medication
Oral Medication
Global Pruritus Ani Medicine Market, by Distribution Channel, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pruritus Ani Medicine Market Segment Percentages, by Distribution Channel, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Pruritus Ani Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pruritus Ani Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pruritus Ani Medicine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pruritus Ani Medicine revenues share in global market, 2022 (%)
Key companies Pruritus Ani Medicine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pruritus Ani Medicine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie, Inc. (Allergan plc)
Albireo Pharma, Inc.
Astellas Pharma Inc.
Cipla Limited
Eli Lilly and Company
GSK plc
Merck & Co., Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc. (Mylan N.V.)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pruritus Ani Medicine, market overview.
Chapter 2: Global Pruritus Ani Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Pruritus Ani Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pruritus Ani Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pruritus Ani Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Pruritus Ani Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global Pruritus Ani Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pruritus Ani Medicine Overall Market Size
2.1 Global Pruritus Ani Medicine Market Size: 2022 VS 2029
2.2 Global Pruritus Ani Medicine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pruritus Ani Medicine Sales: 2018-2029
3 Company Landscape
3.1 Top Pruritus Ani Medicine Players in Global Market
3.2 Top Global Pruritus Ani Medicine Companies Ranked by Revenue
3.3 Global Pruritus Ani Medicine Revenue by Companies
3.4 Global Pruritus Ani Medicine Sales by Companies
3.5 Global Pruritus Ani Medicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pruritus Ani Medicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pruritus Ani Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pruritus Ani Medicine Players in Global Market
3.8.1 List of Global Tier 1 Pruritus Ani Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pruritus Ani Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pruritus Ani Medicine Market Size Markets, 2022 & 2029
4.1.2 External Medication
4.1.3 Oral Medication
4.2 By Type - Global Pruritus Ani Medicine Revenue & Forecasts
4.2.1 By Type - Global Pruritus Ani Medicine Revenue, 2018-2023
4.2.2 By Type - Global Pruritus Ani Medicine Revenue, 2024-2029
4.2.3 By Type - Global Pruritus Ani Medicine Revenue Market Share, 2018-2029
4.3 By Type - Global Pruritus Ani Medicine Sales & Forecasts
4.3.1 By Type - Global Pruritus Ani Medicine Sales, 2018-2023
4.3.2 By Type - Global Pruritus Ani Medicine Sales, 2024-2029
4.3.3 By Type - Global Pruritus Ani Medicine Sales Market Share, 2018-2029
4.4 By Type - Global Pruritus Ani Medicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Distribution Channel
5.1 Overview
5.1.1 By Distribution Channel - Global Pruritus Ani Medicine Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Distribution Channel - Global Pruritus Ani Medicine Revenue & Forecasts
5.2.1 By Distribution Channel - Global Pruritus Ani Medicine Revenue, 2018-2023
5.2.2 By Distribution Channel - Global Pruritus Ani Medicine Revenue, 2024-2029
5.2.3 By Distribution Channel - Global Pruritus Ani Medicine Revenue Market Share, 2018-2029
5.3 By Distribution Channel - Global Pruritus Ani Medicine Sales & Forecasts
5.3.1 By Distribution Channel - Global Pruritus Ani Medicine Sales, 2018-2023
5.3.2 By Distribution Channel - Global Pruritus Ani Medicine Sales, 2024-2029
5.3.3 By Distribution Channel - Global Pruritus Ani Medicine Sales Market Share, 2018-2029
5.4 By Distribution Channel - Global Pruritus Ani Medicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Pruritus Ani Medicine Market Size, 2022 & 2029
6.2 By Region - Global Pruritus Ani Medicine Revenue & Forecasts
6.2.1 By Region - Global Pruritus Ani Medicine Revenue, 2018-2023
6.2.2 By Region - Global Pruritus Ani Medicine Revenue, 2024-2029
6.2.3 By Region - Global Pruritus Ani Medicine Revenue Market Share, 2018-2029
6.3 By Region - Global Pruritus Ani Medicine Sales & Forecasts
6.3.1 By Region - Global Pruritus Ani Medicine Sales, 2018-2023
6.3.2 By Region - Global Pruritus Ani Medicine Sales, 2024-2029
6.3.3 By Region - Global Pruritus Ani Medicine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Pruritus Ani Medicine Revenue, 2018-2029
6.4.2 By Country - North America Pruritus Ani Medicine Sales, 2018-2029
6.4.3 US Pruritus Ani Medicine Market Size, 2018-2029
6.4.4 Canada Pruritus Ani Medicine Market Size, 2018-2029
6.4.5 Mexico Pruritus Ani Medicine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Pruritus Ani Medicine Revenue, 2018-2029
6.5.2 By Country - Europe Pruritus Ani Medicine Sales, 2018-2029
6.5.3 Germany Pruritus Ani Medicine Market Size, 2018-2029
6.5.4 France Pruritus Ani Medicine Market Size, 2018-2029
6.5.5 U.K. Pruritus Ani Medicine Market Size, 2018-2029
6.5.6 Italy Pruritus Ani Medicine Market Size, 2018-2029
6.5.7 Russia Pruritus Ani Medicine Market Size, 2018-2029
6.5.8 Nordic Countries Pruritus Ani Medicine Market Size, 2018-2029
6.5.9 Benelux Pruritus Ani Medicine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Pruritus Ani Medicine Revenue, 2018-2029
6.6.2 By Region - Asia Pruritus Ani Medicine Sales, 2018-2029
6.6.3 China Pruritus Ani Medicine Market Size, 2018-2029
6.6.4 Japan Pruritus Ani Medicine Market Size, 2018-2029
6.6.5 South Korea Pruritus Ani Medicine Market Size, 2018-2029
6.6.6 Southeast Asia Pruritus Ani Medicine Market Size, 2018-2029
6.6.7 India Pruritus Ani Medicine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Pruritus Ani Medicine Revenue, 2018-2029
6.7.2 By Country - South America Pruritus Ani Medicine Sales, 2018-2029
6.7.3 Brazil Pruritus Ani Medicine Market Size, 2018-2029
6.7.4 Argentina Pruritus Ani Medicine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pruritus Ani Medicine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Pruritus Ani Medicine Sales, 2018-2029
6.8.3 Turkey Pruritus Ani Medicine Market Size, 2018-2029
6.8.4 Israel Pruritus Ani Medicine Market Size, 2018-2029
6.8.5 Saudi Arabia Pruritus Ani Medicine Market Size, 2018-2029
6.8.6 UAE Pruritus Ani Medicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie, Inc. (Allergan plc)
7.1.1 AbbVie, Inc. (Allergan plc) Company Summary
7.1.2 AbbVie, Inc. (Allergan plc) Business Overview
7.1.3 AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Major Product Offerings
7.1.4 AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie, Inc. (Allergan plc) Key News & Latest Developments
7.2 Albireo Pharma, Inc.
7.2.1 Albireo Pharma, Inc. Company Summary
7.2.2 Albireo Pharma, Inc. Business Overview
7.2.3 Albireo Pharma, Inc. Pruritus Ani Medicine Major Product Offerings
7.2.4 Albireo Pharma, Inc. Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.2.5 Albireo Pharma, Inc. Key News & Latest Developments
7.3 Astellas Pharma Inc.
7.3.1 Astellas Pharma Inc. Company Summary
7.3.2 Astellas Pharma Inc. Business Overview
7.3.3 Astellas Pharma Inc. Pruritus Ani Medicine Major Product Offerings
7.3.4 Astellas Pharma Inc. Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.3.5 Astellas Pharma Inc. Key News & Latest Developments
7.4 Cipla Limited
7.4.1 Cipla Limited Company Summary
7.4.2 Cipla Limited Business Overview
7.4.3 Cipla Limited Pruritus Ani Medicine Major Product Offerings
7.4.4 Cipla Limited Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.4.5 Cipla Limited Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Pruritus Ani Medicine Major Product Offerings
7.5.4 Eli Lilly and Company Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 GSK plc
7.6.1 GSK plc Company Summary
7.6.2 GSK plc Business Overview
7.6.3 GSK plc Pruritus Ani Medicine Major Product Offerings
7.6.4 GSK plc Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.6.5 GSK plc Key News & Latest Developments
7.7 Merck & Co., Inc.
7.7.1 Merck & Co., Inc. Company Summary
7.7.2 Merck & Co., Inc. Business Overview
7.7.3 Merck & Co., Inc. Pruritus Ani Medicine Major Product Offerings
7.7.4 Merck & Co., Inc. Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.7.5 Merck & Co., Inc. Key News & Latest Developments
7.8 Pfizer, Inc.
7.8.1 Pfizer, Inc. Company Summary
7.8.2 Pfizer, Inc. Business Overview
7.8.3 Pfizer, Inc. Pruritus Ani Medicine Major Product Offerings
7.8.4 Pfizer, Inc. Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer, Inc. Key News & Latest Developments
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.10 Viatris Inc. (Mylan N.V.)
7.10.1 Viatris Inc. (Mylan N.V.) Company Summary
7.10.2 Viatris Inc. (Mylan N.V.) Business Overview
7.10.3 Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Major Product Offerings
7.10.4 Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Sales and Revenue in Global (2018-2023)
7.10.5 Viatris Inc. (Mylan N.V.) Key News & Latest Developments
8 Global Pruritus Ani Medicine Production Capacity, Analysis
8.1 Global Pruritus Ani Medicine Production Capacity, 2018-2029
8.2 Pruritus Ani Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pruritus Ani Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pruritus Ani Medicine Supply Chain Analysis
10.1 Pruritus Ani Medicine Industry Value Chain
10.2 Pruritus Ani Medicine Upstream Market
10.3 Pruritus Ani Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pruritus Ani Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe